Home›Stock Screener›Zenith Drugs

Zenith Drugs Share Price Today | Stock Price & Zenith Drugs Share Screener

ZENITHDRUG Pharmaceuticals & Biotechnology

Track the current Zenith Drugs share price and stock price live with TickJournal's free stock screener. Track ZENITHDRUG market capitalization to gauge the company's total market size. Use the Zenith Drugs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Zenith Drugs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Zenith Drugs Market Cap ₹72.02 Cr.
ZENITHDRUG P/E Ratio (TTM) -
Zenith Drugs P/B Ratio 0.98
EPS (TTM) ₹5.63
Dividend Yield 1.19%
Debt to Equity 0.63
ZENITHDRUG 52 Week High -
Zenith Drugs 52 Week Low -
Operating Margin -
Profit Margin -
ZENITHDRUG Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹135.00
Total Equity ₹62.00

Zenith Drugs Share Price Chart

Track the current stock price of Zenith Drugs with an interactive chart. Analyse ZENITHDRUG share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Zenith Drugs stock quote in one place.

Zenith Drugs Company Profile - Fundamental Screener

Screen Zenith Drugs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ZENITHDRUG shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0QWN01013.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0QWN01013

Zenith Drugs Balance Sheet Screener

Screen ZENITHDRUG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2024, total assets were ₹135, up from ₹98 in 2023.

Latest statistics put total assets at ₹135 and shareholder funds at ₹62, with a leverage ratio of 0.63.

Item 2024 2023 2022

Assets

Total Assets 135 98 69
Current Assets 0 0 0
Fixed Assets 11 12 11

Liabilities

Total Liabilities 0 0 0
Current Liabilities 9 9 10
Non-Current Liabilities 0 0 0

Shareholders' Equity

Total Equity 62 18 12
Share Capital 17 0 0
Reserves & Surplus 45 17 12

Zenith Drugs Income Statement Screener - Profit & Revenue Analysis

Screen Zenith Drugs income statement and profit fundamentals. Analyze ZENITHDRUG quarterly results. Zenith Drugs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2024-March, shows revenue of ₹134 and net profit of ₹10.

Item None-None 2024-March 2023-March 2022-March

Revenue and Expenses

Revenue 0 134 116 93
Expenses 0 115 106 85

Operating Costs and Margins

EBITDA 0 19 10 8
Operating Profit % 0.00% 13.00% 8.00% 7.00%
Depreciation 0 1 1 1
Interest 0 3 2 2

Profit and Earnings

Profit Before Tax 0 13 7 4
Tax 0 4 2 1
Net Profit 0 10 5 3
EPS 0.00 5.63 122.02 78.22

Zenith Drugs Cash Flow Screener - Liquidity Fundamentals

Screen ZENITHDRUG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2024-March, operating activities used ₹13, and net cash flow was an inflow of ₹9.

Over the same period, investing activities provided ₹26 and financing activities used ₹5.

Item 2024-March 2023-March 2022-March

Cash from Operations and Investing

Operating Activities -13 -5 5
Investing Activities 26 0 -5

Financing and Net Cash

Financing Activities -5 5 1
Net Cash Flow 9 0 1

Zenith Drugs Shareholding Pattern Screener

See Zenith Drugs shareholding pattern with promoter, FII, and DII holdings. Check Zenith Drugs promoter holding and ownership changes for ZENITHDRUG on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 69.98%, foreign institutions 0.00%, domestic institutions 0.00% and the public 24.73%, spread across 1,435 shareholders.

The shareholder count was 1,435 in 2026-Mar, compared with 1,317 in 2026-Sept.

Item 2026-Mar 2026-Sept 2025-Mar 2025-Sept 2024-Feb 2024-Mar 2024-Sept 2023-Sept

Promoter Holding

Promoter Holding 69.98% 69.98% 69.98% 69.98% 100.00% 69.98% 69.98% 100.00%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 24.73% 24.94% 25.56% 25.25% 0.00% 15.20% 25.57% 0.00%
Other Holding 5.29% 5.08% 4.46% 4.77% 0.00% 14.83% 4.45% 0.00%
Shareholder Count 1,435 1,317 1,544 1,466 7 1,117 1,355 7

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Zenith Drugs. Zenith Drugs dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.50 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.50 0.70%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

Zenith Drugs Stock Index Membership - Nifty & Sensex

See which indices include Zenith Drugs stock. Check ZENITHDRUG index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Zenith Drugs is not part of any tracked indices.
Only major market indices are tracked in our system.

Zenith Drugs Market Events Screener - Corporate Actions

Get Zenith Drugs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Zenith Drugs stock events that may affect ZENITHDRUG share price, along with derivatives, futures and options activity and sector gainers.

8 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Extraordinary General Meeting dated July 23, 2026 and Quarterly Result Announcement dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA 8.79%
2026-07-23 2026-07-23 Extraordinary General Meeting NA 5.84%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 16.69%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -4.67%
2025-05-29 2025-05-29 Quarterly Result Announcement NA 0.76%
2024-11-14 2024-11-14 Quarterly Result Announcement NA -6.06%
2024-09-25 2024-09-25 Annual General Meeting NA 17.15%
2024-09-17 2024-09-18 Dividend ₹ 0.50 /share 107.89%

Zenith Drugs Competitors Screener - Peer Stocks Comparison

Screen ZENITHDRUG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,219 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 295,652 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,069 84.70 13,886 20.34% 2,138 47.23
Laurus Labs 126,206 94.90 6,868 22.01% 890 57.04
Zydus Life Science 119,800 27.90 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 116,755 42.00 35,059 3.90% 4,158 71.26
Cipla 114,942 39.20 29,045 2.24% 3,870 53.06
Mankind Pharma 108,792 47.50 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,528 25.90 34,145 5.56% 3,503 60.39
Lupin 91,046 17.10 29,039 26.75% 5,356 39.39

Zenith Drugs Company Announcements - News & Reports Screener

Screen ZENITHDRUG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/B ratio is 0.98. Market capitalisation stands at ₹72.02 Cr and the dividend yield is 1.19%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 22, 2026. This page covers 3 balance sheet periods, 4 income statement periods, 3 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.